www.coringroup.com

 


































 

 
   

Hip Resurfacing provides younger, more active patients with an alternative choice of treatment for degenerative hip disease. It offers significant advantages compared to conventional Total Hip Replacement – the implant should last longer and is more stable – allowing a return to a more normal lifestyle for those patients who wish to remain active.

Modern Hip Resurfacing was pioneered and developed by Corin, a British company based in Cirencester, in the South-West of England.  In clinical use since 1991, Corin Hip Resurfacing implants are used by hundreds of surgeons around the world.
  Resuperficializacion de la cadera de Cormet
     
Within this site you can find out exactly what conventional Total Hip Replacement involves and how it differs from Hip Resurfacing. A series of Frequently asked Questions are answered, and a summary of available Clinical Results is provided. You can use the Locate A Surgeon form to request information about surgeons in your area who use this technique, and in Local Information you can find out about Hip Resurfacing in your country.

In the Case Studies section you can read the personal stories of just a few of the many thousands of patients who have chosen Hip Resurfacing as their treatment option.

The information contained within this site has been designed for you, the patient.  It is presented in lay terms and is intended to help you make an informed choice with regard to your choice of treatment.

If you would like more information, or have specific questions you would like answered, do not hesitate to contact us using the comments form provided.

A patient Information Pack is available free of charge, and includes a 16-page booklet and a 20-minute video, explaining Hip Resurfacing, who it is suitable for, and including interviews with two patients. You can request a copy of the Pack by calling the Corin Hip Resurfacing Helpline on 01285 649230 (from the UK) or +44 1285 649230 (international). 

Note:  USA patients - The Cormet device is now approved by the FDA for general use by appropriately trained surgeons.  Stryker Orthopaedics is our marketing and distribution partner for this device in the USA and therefore all enquiries and requests should be directed to Stryker at www.stryker.com